AP4M1 and hepatocellular carcinoma: In addition, AP4M1 can be used for the prediction of immune cell infiltration and immune phenotype in hepatocellular carcinoma and positively correlates with various immune checkpoint-related genes, which laid a foundation for future new immunotherapies for HCC.